BI Asset Management Fondsmaeglerselskab A/S

Position in EXEL — Exelixis, Inc.

CIK 1778131 KOBENHAVN, G7

Position in EXEL

as of Mar 31, 2026 · filed Apr 16, 2026 Compact

Position Value

$6,533,004

+$4,619,474 QoQ

Shares Held

152,320

+248.9% QoQ

Ownership

0.061%

of shares outstanding

% of Portfolio

0.07%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Mar 2020

9 quarters on record

Voting authority Sole 100.ToString("F0")% Shared 0.ToString("F0")% None 0.ToString("F0")%

Healthcare · as of Mar 31, 2026

BI Asset Management Fondsmaeglerselskab A/S holds $81,144,167 across 10 Biotechnology names. EXEL ranks #5 (8.1% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	VRTX	Vertex Pharmaceuticals Inc / Ma	49,531	$22,117,572
2	TECH	BIO-TECHNE Corp	316,510	$16,540,812
3	INCY	Incyte Corp	155,246	$14,611,753
4	HALO	Halozyme Therapeutics, Inc.	148,752	$9,613,841
5	EXEL	Exelixis, Inc. This page	152,320	$6,533,004
6	PTCT	Ptc Therapeutics, Inc.	81,878	$5,578,348
7	REGN	Regeneron Pharmaceuticals, Inc.	3,239	$2,502,580
8	ALNY	Alnylam Pharmaceuticals, Inc.	5,697	$1,884,966

9 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$6,533,004	152,320	+248.9%	Shares	Defined	2026-04-16
2025-12-31	$1,913,530	43,658	-74.9%	Shares	Defined	2026-02-11
2025-09-30	$7,177,361	173,786	+126.0%	Shares	Defined	2025-11-05
2025-06-30	$3,389,399	76,892	-63.9%	Shares	Defined	2025-08-14
2025-03-31	$7,857,425	212,823	+4377.7%	Shares	Defined	2025-05-14
2024-12-31	$158,274	4,753	-87.3%	Shares	Defined	2025-02-13
2020-09-30	$914,185	37,390	0.0%	Shares	Defined	2020-11-09
2020-06-30	$887,638	37,390	-48.8%	Shares	Defined	2020-08-05
2020-03-31	$1,258,351	73,075	—	Shares	Defined	2020-05-11
No filing history on record for this holder in this stock.